These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 38214328)
1. Prognostic impact of Ki-67 in canine splenic hemangiosarcoma: A preliminary study. Brigandì E; Valenti P; Bacci B; Brunetti B; Avallone G Vet Pathol; 2024 Jul; 61(4):534-540. PubMed ID: 38214328 [TBL] [Abstract][Full Text] [Related]
2. Outcomes of 43 small breed dogs treated for splenic hemangiosarcoma. Story AL; Wavreille V; Abrams B; Egan A; Cray M; Selmic LE Vet Surg; 2020 Aug; 49(6):1154-1163. PubMed ID: 32562436 [TBL] [Abstract][Full Text] [Related]
3. Circulating nucleosomes as a potential cancer biomarker in dogs with splenic nodular lesions. Meazzi S; Martini V; Marconato L; Aralla M; Licenziato L; Olimpo M; Roccabianca P; Sabattini S; Ubiali A; Zaccone R; Aresu L Vet Q; 2024 Dec; 44(1):1-7. PubMed ID: 39224020 [TBL] [Abstract][Full Text] [Related]
4. A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs. Grimes JA; Prasad N; Levy S; Cattley R; Lindley S; Boothe HW; Henderson RA; Smith BF BMC Vet Res; 2016 Dec; 12(1):272. PubMed ID: 27912752 [TBL] [Abstract][Full Text] [Related]
5. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993). Wood CA; Moore AS; Gliatto JM; Ablin LA; Berg RJ; Rand WM J Am Anim Hosp Assoc; 1998; 34(5):417-21. PubMed ID: 9728473 [TBL] [Abstract][Full Text] [Related]
6. Understanding the Efficiency of Splenic Hemangiosarcoma Diagnosis Using Monte Carlo Simulations. Herman EJ; Stern AW; Fox RJ; Dark MJ Vet Pathol; 2019 Nov; 56(6):856-859. PubMed ID: 31422751 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of clinical and histologic factors associated with survival time in dogs with stage II splenic hemangiosarcoma treated by splenectomy and adjuvant chemotherapy: 30 cases (2011-2014). Moore AS; Rassnick KM; Frimberger AE J Am Vet Med Assoc; 2017 Sep; 251(5):559-565. PubMed ID: 28828962 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma. Adachi M; Hoshino Y; Izumi Y; Takagi S J Vet Med Sci; 2016 May; 78(4):649-56. PubMed ID: 26685984 [TBL] [Abstract][Full Text] [Related]
9. Splenomegaly in dogs. Predictors of neoplasia and survival after splenectomy. Johnson KA; Powers BE; Withrow SJ; Sheetz MJ; Curtis CR; Wrigley RH J Vet Intern Med; 1989; 3(3):160-6. PubMed ID: 2778749 [TBL] [Abstract][Full Text] [Related]
10. Laparoscopic splenectomy for treatment of splenic hemangiosarcoma in a dog. Collard F; Nadeau ME; Carmel EN Vet Surg; 2010 Oct; 39(7):870-2. PubMed ID: 20723196 [TBL] [Abstract][Full Text] [Related]
11. [Hemangiosarcoma of the spleen: clinical aspects in 52 dogs]. Kessler M; Maurus Y; Köstlin R Tierarztl Prax Ausg K Kleintiere Heimtiere; 1997 Nov; 25(6):651-6. PubMed ID: 9459832 [TBL] [Abstract][Full Text] [Related]
12. Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomy. Faroni E; Sabattini S; Guerra D; Iannuzzi C; Chalfon C; Agnoli C; Stefanello D; Polton G; Ramos S; Aralla M; Ciaccini R; Foglia A; Okonji S; Marconato L Vet Comp Oncol; 2023 Mar; 21(1):123-130. PubMed ID: 36633399 [TBL] [Abstract][Full Text] [Related]
13. Splenic masses in dogs. Part 1: Epidemiologic, clinical characteristics as well as histopathologic diagnosis in 249 cases (2000-2011). Eberle N; von Babo V; Nolte I; Baumgärtner W; Betz D Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):250-60. PubMed ID: 22911256 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of p53 and pp53 Ser García-Iglesias MJ; Cuevas-Higuera JL; Bastida-Sáenz A; de Garnica-García MG; Polledo L; Perero P; González-Fernández J; Fernández-Martínez B; Pérez-Martínez C BMC Vet Res; 2020 Jul; 16(1):239. PubMed ID: 32660487 [TBL] [Abstract][Full Text] [Related]
15. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004). Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000 [TBL] [Abstract][Full Text] [Related]
16. Refining the "double two-thirds" rule: Genotype-based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogs. Davies O; Taylor AJ Vet Comp Oncol; 2020 Dec; 18(4):548-558. PubMed ID: 32043696 [TBL] [Abstract][Full Text] [Related]
17. Prospective study of successful autologous dendritic cell therapy in dogs with splenic stage II hemangiosarcoma. Spiller V; Vetter M; Dettmer-Richardt C; Grammel T Vet J; 2024 Aug; 306():106196. PubMed ID: 39004264 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of hemangiosarcoma in anemic dogs with a splenic mass and hemoperitoneum requiring a transfusion: 71 cases (2003-2005). Hammond TN; Pesillo-Crosby SA J Am Vet Med Assoc; 2008 Feb; 232(4):553-8. PubMed ID: 18279091 [TBL] [Abstract][Full Text] [Related]
19. Littoral cell angiosarcoma in a dog. Gal A; Yamate J; Golbar HM; Spoerer K; Fredrickson R J Comp Pathol; 2013; 149(2-3):221-4. PubMed ID: 23453493 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study. Borgatti A; Winter AL; Stuebner K; Scott R; Ober CP; Anderson KL; Feeney DA; Vallera DA; Koopmeiners JS; Modiano JF; Froelich J PLoS One; 2017; 12(2):e0172651. PubMed ID: 28222142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]